CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 21 enrolled
Drug / intervention
Low Level Laser Therapy +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01351376
NCT01351376N/ACompleted
CompareCT.gov

The Effectiveness of Low Level Laser Therapy (LLLT)Combined With Complex Decongestive Therapy (CDT) in the Treatment of Breast Cancer-Related Lymphedema: A Double-Blind, Randomized, Placebo-Controlled Study

NYU Langone Health·interventional·Posted May 10, 2011·Updated Sep 19, 2019

In Brief

A clinical study evaluating Low Level Laser Therapy and Low Level Laser for Breast Cancer and Lymphedema. Completed, enrolled 21 participants across 3 sites.

Detailed Summary

This study aims to explore the effects of Low Level Laser Therapy (LLLT) on breast cancer-related lymphedema when utilized in conjunction with Complex Decongestive Therapy (CDT) when compared to CDT treatment alone. The investigators hypothesize that the addition of LLLT to CDT will result in statistically significant improvements and greater long-term benefits as measured by changes in arm volume and quality of life when compared to the benefits of CDT alone for the treatment of breast cancer-related lymphedema.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer, Lymphedema
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedMay 10, 2011
Enrollment StartMay 1, 2011
Primary CompletionJun 1, 2016
Study CompletionJul 1, 2017
TodayJul 2, 2026
Enrollment to primary: 5.1 yearsPosted 15.1 years ago

Interventions

Low Level Laser Therapydevice

Placebo LLL combined with CDT

Low Level Laserdevice

Active LLL combined with CDT